Cogent Biosciences shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Cogent Biosciences (COGT) shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Cogent Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Cogent Biosciences held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Cogent Biosciences by Ubs Global Asset Management Americas
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $2.1M | 143k | 14.36 |
| 2025-06-30 | $1.5M | 207k | 7.18 |
| 2025-03-31 | $888k | 148k | 5.99 |
| 2024-12-31 | $1.1M | 136k | 7.80 |
| 2024-09-30 | $1.3M | 118k | 10.80 |
| 2024-06-30 | $1.1M | 126k | 8.43 |
| 2024-03-31 | $467k | 70k | 6.72 |
| 2023-12-31 | $350k | 60k | 5.88 |
| 2023-09-30 | $504k | 52k | 9.75 |
| 2023-06-30 | $240k | 22k | 10.79 |
| 2023-03-31 | $240k | 22k | 10.79 |
| 2022-12-31 | $257k | 22k | 11.56 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas